Husain Attarwala

Company: Aera Therapeutics

Job title: Vice President, Bioanalytics, DMPK, Clinical Pharmacology & Pharmacometrics

Seminars:

Mechanistic IS/ID Modeling to Enable Pediatric Vaccine Dose Selection: A Case Study in Predictive Immunogenicity Accelerating Innovation to Optimize Dosing & Speed Up Time-to-Market 11:30 am

Learn how mechanistic IS/ID modeling can be applied to inform pediatric vaccine dose selection with predictive confidence Understand how model-informed development streamlines clinical trial design and supports regulatory interactions Gain actionable insights into implementing scalable modeling strategies to accelerate vaccine development across age groupsRead more

day: Day 2